
    
      The patient was given a daily dose of apatinib 500mg (or based on weight). Individualized
      chemotherapy regimens were given based on molecular expression and prior chemotherapy. Brain
      MRI+MRS was examined every 3 months; Blood routine, urine routine and liver and kidney
      function were examined once a week.
    
  